$2.81 - GNLX | Genelux Corporation Common Stock

Genelux Corporation Common Stock (GNLX)

Genelux Corporation Common Stock

XNAS:GNLX

2.81

3.31%

Ask

$3.00 - 100.00

Bid

$2.62 - 1,000.00

Low

$2.75

High

$2.9

Open

$2.88

Prev Close

$2.72

52W High

8.54

52W Low

1.99

Volume

818126

Avg Vol (3m)

429915.5

Float

33115884.65

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 01/26/2023

Primary Exchange: XNAS

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Phone: 805-267-9889

Address: 2625 Townsgate Road, Suite 230

City: Westlake Village

State: CA

Postal Code: 91361

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-3.180000

P/B (TTM)

5.665030

Round Lot

100

Composit FIGI

BBG0044BNBX6

Share Class FIGI

BBG0044BNBY5

Share Class Shares Outstanding

37.77M

Weighted Shares Outstanding

37.77M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion